On Thursday, April 12, Health Affairs will hold a briefing to unveil its April 2012 issue, “Issues In Cancer Care: Value, Costs & Quality.” The volume explores a range of cancer-related topics, with the centerpiece a cluster of articles on assessing the value of high-cost cancer treatments.  The cluster received funding support from Bristol-Myers Squibb; the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California; and Precision Health Economics.

Please join us for the briefing at the W Hotel Washington, at 515 15th St. NW, on April 12, 8:30 a.m. – 1:30 p.m.  Register now.

The authors of articles in this issue will discuss the following:

  • The Value Of Higher Cancer Spending in the United States Versus Europe
  • How Cancer Patients Assign Value To Hope
  • Challenges Of Assessing Value In Cancer Care for Medicare And Other Payers
  • Are We Spending Money Appropriately In Cancer Care? The Case Of Prostate Cancer
  • The Case For Lung Cancer Screening of High-Risk Patients
  • Improving Payment And Delivery Of Cancer Care
  • Variations, Best Practices And Patients’ Choices In Advanced Cancer And End-Of-Life Care

Twitter: To read live tweets from the briefing, follow @HA_Events or search for the hashtag #HA_Cancer.

The authors who will speak include (in alphabetical order):

  • Amy J. Berman, Breast cancer patient speaking from her experience and her April Narrative Matters essay; Senior Program Officer, John A. Hartford Foundation
  • Douglas W. Blayney, Ann and John Doerr Medical Director, Stanford University Cancer Center
  • Dana Goldman, Director, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California
  • Bruce L. Jacobs, Fellow, Urologic Oncology, Health Services Research, University of Michigan
  • Darius Lakdawalla, Director of Research, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California
  • J. Ross MacLean, Vice President, Health Services, Bristol-Myers Squibb
  • Danil V. Makarov, Assistant Professor of Urology, New York University School of Medicine, and Assistant Professor of Health Policy, NYU Wagner School of Public Service
  • Joshua N. Mirkin, State University of New York Downstate College of Medicine
  • Jean Mitchell, Professor, Georgetown University Public Policy Institute
  • Nancy E. Morden, Dartmouth Institute for Health Policy and Clinical Practice
  • Peter Neumann, Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Professor of Medicine, Tufts University School of Medicine
  • Tomas J. Philipson, Daniel Levin Professor of Public Policy Studies, University of Chicago
  • Bruce S. Pyenson, Principal, Milliman
  • John A. Romley, School of Policy, Planning and Development, and Economist, Leonard D. Schaeffer Center for Health Economics and Policy, University of Southern California
  • Peter Ubel, Professor of Marketing and Public Policy, Duke University